Reporter Maxmen digs into why unproven peptides have caught on with wellness influencers, biohackers and some doctors. The full reporting is linked from KFF's profile.
Recap by typeshit. Post by @kffhealthnews on Instagram.
Reuters reports the trend among GLP-1 users is prompting calls for tighter rules on supplements sold alongside the drugs.
A pharmacist account flags two separate Class II recalls involving compounded tirzepatide. Tap through for which products are affected and why.
Health authorities in New South Wales issued a warning after a jump in hospitalisations linked to unapproved peptides sold as wellness products.
A University of Iowa chemist found no peptide in a Brooklyn corner-store vial, and another expert flagged at least 13 bacterial colonies that could cause infection.
Researchers in Granada report that combining intermittent fasting and exercise over 12 weeks improved fat loss and fitness in adults with obesity.
Hanmi says the WHO listed an international nonproprietary name for its next obesity candidate, following its earlier drug efpeglenatide.
Loading…